NCT05241015Completed
Effect of Sensorimotor Training on Upper Extremity in Parkinson's Patients
Investigation of the Effect of Sensorimotor Training on Upper Extremity Functions, Activity and Participation in Parkinson's Patients
Source: ClinicalTrials.gov · Last updated 22 Feb 2024
Brief summary (registry, in English)
There are many factors affecting the upper extremity such as tremor, bradykinesia, rigidity, and postural instability in Parkinson's patients. According to the International Classification of Functioning, Disability and Health (ICF) model, there are restrictions on people's activities and participation in life due to structural and functional disorders affecting the upper extremity in PD. In PD, integrating and using proprioceptive feedback, sensorimotor integration and peripheral sensory functions are reported to be impaired. Numerous studies show that the main source of motor problems in PD is dysfunction of sensorimotor integration. Since the cervical region contains a dense concentration of proprioceptive organs such as muscle spindles, it plays an important role in providing afferent proprioceptive information for postural control. Therefore, sensorimotor training targeting the cervical region gains importance. In this study, we aim to reduce PD-specific upper extremity disorders and related activity and participation limitations by increasing motor control in the cervical region with sensorimotor training. Patients with Parkinson's disease will be included in the study and randomly divided into 2 groups. While the general physiotherapy program will be applied to the control group, sensorimotor training will be given in addition to the exercise group.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 27 (actual)
- First submitted
- 7 Jan 2022
- Start date
- 8 Dec 2021
- Primary completion date
- 20 Nov 2023
- Lead sponsor
- Hacettepe University
- Diseases
- Parkinson disease
- NCT number
- NCT05241015
What you commit to
- Study type: Interventional
- Participants enrolled: 27
- From 8 Dec 2021 to the primary completion date, 20 Nov 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients receiving device-assisted therapy
- Patients receiving apomorphine therapy
- Patients who use drugs (antidepressants, etc.) that will affect cognitive functions
Other
- Patients with mini mental test scores below 24
- Patients with hearing and speech problems
- Patients with orthopedic, neurological and vestibular problems other than Parkinson's that may prevent them from completing the tests and treatment
Who the study is looking for
- Having idiopathic Parkinson's disease over the age of 40
- Meets the diagnostic criteria of the United Kingdom Parkinson's Disease Society Brain Bank
- Hoehn-Yahr Staging \<3
- Mini mental test score of 24 and above
- In the "on" period
- Receiving oral therapy only
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Nuh Naci Yazgan University, Department of Physiotherapy and Rehabilitation Coordinator of this site? Confirm its status | Kayseri | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.